Capstone Triton Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-440
Closed -$229K 110
2023
Q2
$229K Hold
440
0.16% 94
2023
Q1
$253K Buy
+440
New +$248K 0.19% 87
2022
Q1
Sell
-456
Closed -$303K 118
2021
Q4
$303K Hold
456
0.61% 61
2021
Q3
$277K Sell
456
-14
-3% -$7.68K 0.17% 98
2021
Q2
$237K Hold
470
0.15% 108
2021
Q1
$215K Hold
470
0.14% 108
2020
Q4
$219K Buy
+470
New +$220K 0.13% 100

Other funds holding TMO

Capstone Triton Financial Group's TMO Position: Q3 2023 in Review

Capstone Triton Financial Group sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 440 shares — an estimated $229K sold.

Capstone Triton Financial Group first reported a position in TMO in Q4 2020 and held it in 7 quarters. The position peaked at $303K in Q4 2021. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Capstone Triton Financial Group reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Capstone Triton Financial Group sold 440 Thermo Fisher Scientific shares in Q3 2023, an estimated $229K.
  • Capstone Triton Financial Group first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 7 quarters.
  • Capstone Triton Financial Group's Thermo Fisher Scientific position peaked at $303K in Q4 2021.
  • 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Capstone Triton Financial Group's 13F filing for Q3 2023, filed 11 Oct 2023.